Security Check

Sun Yat-sen University Cancer Center

Fudan University China Hospital Rankings: Comprehensive A+++
Top Specialties
Oncology
Ranked 2nd nationally; STEM ranked 1st in Oncology.
Thoracic Surgery
Ranked in the national top 10 for specialty reputation.
Nasopharyngeal Carcinoma
PD-1 therapy improves 3-year EFS by up to 10%.
Hospital Introduction
Established in March 1964, Sun Yat-sen University Cancer Center (SYSUCC) is a Grade 3A hospital directly administered by the NHC. It is one of the largest and most academically powerful oncology bases in China, integrating medical treatment, education, research, and prevention.
Grade 3A Hospital
National Key Discipline
WHO Collab Center
GCP Center
International Patient Service
Book Consultation
Hospital Tier
Tertiary Grade-A
Ownership
Public Hospital
Location
Guangzhou, China
Established
1964
Address
651 Dongfeng East Road, Yuexiu District
Sun Yat-sen University Cancer Center
651 Dongfeng East Road, Yuexiu District
Guangzhou, Guangdong, China
2.08 Annual Outpatient Visits (Millions)
206000 Annual Inpatient Discharges
300000 Annual Ultrasound Exams
2243 Total Open Beds

Key Insight: In 2023, ultrasound-guided interventional surgeries exceeded 20,000, and imaging department examinations exceeded 502,000.

Pioneering Care &
Global Oncology Excellence

Sun Yat-sen University Cancer Center (SYSUCC) is a large-scale modern comprehensive hospital directly under the National Health Commission. Integrating advanced medical care, robust education, and cutting-edge research, it has stood as a medical beacon since its inception in 1964.

Boasting a floor area of 180,000 square meters across the Yuexiu and Huangpu campuses, SYSUCC commands an extensive clinical network comprising 2,243 open beds and a staff of around 2,500. Its oncology unit is globally recognized, maintaining the highest academic standards.

Host Unit

State Key Laboratory of Oncology in South China

MOE Key Laboratory
National Clinical Research Center for New Drugs

Fudan University China Hospital Ranking

A+++

Tier 2, Top 21-40 Nationally

Oncology ranked 2nd nationally; STEM ranked 1st in Oncology.

Institutional Status & External Evidence

Ranking / External Evaluation
Fudan Comprehensive Ranking A+++
Hospital Classification / Accreditation
Tertiary Grade 3A Hospital STEM #1 in Oncology
National Designations / Academic Indicators
National GCP Drug Clinical Trial Center WHO Cancer Research Collaborative Center National Pilot Hospital for MDT 5th Globally in Nature Index Impact Factor 24.9 Cancer Communications

National Key Disciplines & Specialties

Oncology

National Key Discipline since 2001; flagship and highest-level academic discipline.

Thoracic Surgery

Entered the national top ten in the Specialty Reputation Rankings.

Nasopharyngeal Carcinoma

PD-1 monoclonal antibody combination therapy improves 3-year EFS by up to 10%.

Colorectal Cancer

pCR rate of 78.4% with dual immunotherapy; zero recurrences at 21.4-month follow-up.

Liver Cancer

Published landmark RCT in Journal of Clinical Oncology in December 2024.

Medical Imaging

Most recently approved National Key Clinical Specialty Construction Unit in 2024.

Medical & Research Innovation Hubs

State Key Laboratory of Oncology in South China
National Drug Clinical Trial Research Center (GCP)
Collaborative Innovation Center for Cancer Medicine
Guangdong Cancer Center
Guangdong Esophageal Cancer Research Institute
Ministry of Education Key Laboratory
Guangdong Provincial Key Laboratory
T-Cell Immunotherapy Demonstration Center
China Center for Integrative Oncology
WHO Cancer Research Collaborative Center

International Medical Services

The hospital has an International Patient Service Medical Center.

  • Sister-hospital relationship with MD Anderson Cancer Center.
  • Awarded the International Science and Technology Cooperation Award.
  • Collaborative ties with Karolinska Institute, University of Warwick, and Erasmus Medical Center.

Global Excellence Standard

The hospital treats patients from across China and Southeast Asia, confirming strong international patient reception capability and providing access to Asia's largest radiation therapy center.

International Academic Partnerships

Empowering international patients through streamlined, top-tier healthcare pathways and cutting-edge robotic-assisted minimally invasive surgeries.

Source & Verification

Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.

Primary Institutional Source Sun Yat-sen University Cancer Center — official hospital website.
Government / Official Records Chinese government and official institutional records reviewed as part of the MedBridge audit process.
MedBridge Verification Hospital entity data has been reviewed against the source records maintained by MedBridge.
QA date: October 6, 2026.